Desmoid fibromatosis: is the current picture changing?

Area of Science:

• Oncology
• Surgical Oncology
• Molecular Oncology

Background:

• Desmoid fibromatosis is a locally aggressive neoplasm with unpredictable behavior.
• Historically, surgical resection was the primary treatment modality.
• Current treatment paradigms are shifting towards less invasive approaches.

Observation:

• Active surveillance has emerged as the preferred front-line management strategy.
• Advances in molecular biology have identified CTNNB1 mutations as significant prognostic markers.
• The review synthesizes current literature and practice guidelines for desmoid fibromatosis.

Findings:

• The management of desmoid fibromatosis is evolving, moving away from surgery towards active surveillance.
• CTNNB1 mutational analysis provides valuable prognostic information.
• Novel therapeutic targets and ongoing clinical trials are being explored.

Implications:

• This review offers insights into the future management of sporadic desmoid fibromatosis.
• Understanding molecular drivers can guide personalized treatment strategies.
• The findings support a more conservative and targeted approach to desmoid fibromatosis care.